Your browser doesn't support javascript.
loading
Plasmodium falciparum exploits CD44 as a coreceptor for erythrocyte invasion.
Baro, Barbara; Kim, Chi Yong; Lin, Carrie; Kongsomboonvech, Angel K; Tetard, Marilou; Peterson, Nana Ansuah; Salinas, Nichole D; Tolia, Niraj H; Egan, Elizabeth S.
Afiliación
  • Baro B; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA.
  • Kim CY; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA.
  • Lin C; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA.
  • Kongsomboonvech AK; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA.
  • Tetard M; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA.
  • Peterson NA; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA.
  • Salinas ND; Host-Pathogen Interactions and Structural Vaccinology Section, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
  • Tolia NH; Host-Pathogen Interactions and Structural Vaccinology Section, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
  • Egan ES; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA.
Blood ; 142(23): 2016-2028, 2023 12 07.
Article en En | MEDLINE | ID: mdl-37832027
The malaria parasite Plasmodium falciparum invades and replicates asexually within human erythrocytes. CD44 expressed on erythrocytes was previously identified as an important host factor for P falciparum infection through a forward genetic screen, but little is known about its regulation or function in these cells, nor how it may be used by the parasite. We found that CD44 can be efficiently deleted from primary human hematopoietic stem cells using CRISPR/Cas9 genome editing, and that the efficiency of ex vivo erythropoiesis to enucleated cultured red blood cells (cRBCs) is not affected by lack of CD44. However, the rate of P falciparum invasion was reduced in CD44-null cRBCs relative to isogenic wild-type control cells, validating CD44 as an important host factor for this parasite. We identified 2 P falciparum invasion ligands as binding partners for CD44, erythrocyte binding antigen 175 (EBA-175) and EBA-140 and demonstrated that their ability to bind to human erythrocytes relies primarily on their canonical receptors, glycophorin A and glycophorin C, respectively. We further show that EBA-175 induces phosphorylation of erythrocyte cytoskeletal proteins in a CD44-dependent manner. Our findings support a model in which P falciparum exploits CD44 as a coreceptor during invasion of human erythrocytes, stimulating CD44-dependent phosphorylation of host cytoskeletal proteins that alter host cell deformability and facilitate parasite entry.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Plasmodium falciparum / Malaria Falciparum / Eritrocitos Límite: Humans Idioma: En Revista: Blood Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Plasmodium falciparum / Malaria Falciparum / Eritrocitos Límite: Humans Idioma: En Revista: Blood Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos